VEGF-A levels were lower in the first week after ROP treatment (laser or anti-VEGF) compared with pretreatment levels (ROM [95% CI] 0.34 [0.25–0.45], I2 = 97%). Here, VEGFA is linked to retinopathy of prematurity.